Review COVID-19 outpatient therapies that are covered by the ninth amendment to the PREP Act Declaration, such as oral antivirals or monoclonal antibodies (mAbs), including indications, contraindications, dosing, administration, and recognition and treatment of emergency adverse reactions. Learn about considerations for logistics and planning when deciding to provide these therapies in an outpatient setting.
- Provider:TRC Healthcare
- Activity Link: https://learning.therapeuticresearch.com
- Start Date: 2022-08-01 05:00:00
- End Date: 2022-08-01 05:00:00
- Credit Details: Pharmacy: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest